Welcome to visit Wang Lian!
Current location:front page >> healthy

Many Grade A hospitals have been punished for medical insurance violations

2025-09-19 01:13:38 healthy

Many Grade A hospitals have been punished for medical insurance violations: Industry reflections on stricter supervision

Recently, the National Health Insurance Administration has released a number of penalties for medical insurance violations in medical institutions, involving many Grade A hospitals across the country. This incident has aroused widespread attention from the society and also reflects the trend of stricter supervision of medical insurance funds. The following are the focus content and structured data analysis that has been hotly discussed across the Internet in the past 10 days.

1. Event background and punishment overview

Many Grade A hospitals have been punished for medical insurance violations

According to the notice from the Medical Insurance Bureau, a total of 12,000 cases of illegal use of medical insurance funds were investigated and dealt with in the third quarter of 2023, and 2.13 billion yuan of funds were recovered. Among them, Grade A hospitals account for 17%, and violations are mainly concentrated in the following aspects:

Violation TypeNumber of hospitals involvedTypical performance
Overdiagnosis and treatment38 companiesNo indication examination, decomposition of hospitalization
False charges25 companiesFalse record surgery items, high fees
Switch projects19 companiesReimbursement of medicine and equipment replacement

2. Analysis of key punishment cases

1.A Grade A Hospital in Beijing: 12.8 million yuan of medical insurance fund was recovered for violations such as "intraoperative price increase" and was punished with a double penalty;
2.A specialized hospital in Shanghai: Fictional records of 44 cataract surgery cases and cancelled the designated medical insurance for one year;
3.A comprehensive hospital in Guangzhou: The president was given a warning and talked with a warning through illegally obtaining funds through "hung bed hospitalization".

areaPenalty amountRectification requirements
North China65.3 million yuanEstablish an intelligent audit system
East China48.2 million yuanImprove the internal audit system
South China31.7 million yuanCarry out full-staff training

3. Public opinion reaction and industry influence

1.Patient voice: More than 72% of respondents support strengthening supervision, but are worried about "accidentally injuring" normal medical needs;
2.Hospital response: Many institutions have stated that they will promote the DRG payment reform, and a provincial hospital has launched an anti-fraud system;
3.Expert opinion: The China Medical Insurance Research Association pointed out that it is necessary to balance the regulatory efforts and medical innovation space.

4. Deep Pivot

yearNumber of cases investigated and dealt withRecover funds (billion yuan)Grade A hospitals account for
202154,00043.512%
202278,00068.215%
2023 (first three seasons)91,00089.718%

5. Future regulatory trend forecast

1.Technology empowerment: Full coverage of the national medical insurance intelligent monitoring subsystem will be achieved by 2024;
2.Standard refinement: The matching requirements for clinical diagnosis and treatment guidelines and medical insurance catalogue have been increased to more than 95%;
3.Joint punishment: It is planned to establish a "blacklist" system and link it with the assessment of the Health Commission.

This incident reflects that the supervision of medical insurance fund has entered the "zero tolerance" stage. How to maintain medical quality while ensuring the safety of the fund will become a transformation issue that medical institutions must face. It is worth noting that data during the same period showed that the use efficiency of hospital medical insurance funds that are standardized to operate increased by 6.8% year-on-year, indicating that compliance and efficiency are not contradictory.

Next article
  • China's pharmaceutical industry faces challenges in realizing capital and asset value, and ushers in new opportunitiesIn recent years, under the influence of policies, markets and capital, China's pharmaceutical industry has experienced rapid development and profound changes. However, with the intensification of industry competition and the changes in the macroeconomic environment, pharmaceutical companies are facing
    2025-09-19 healthy
  • Patient-centered drug development concept is deeply rooted in people's heartsIn recent years, with the advancement of medical technology and the increase in society's demand for health,Patient-Centric Drug Development (PCDD)The concept has gradually become the core trend of the global pharmaceutical industry. This concept emphasizes that in the entire process of drug research and development, starting from the needs
    2025-09-19 healthy
  • Promote the development of traditional Chinese medicine service trade and support the construction of national traditional Chinese medicine service export basesIn recent years, the influence of traditional Chinese medicine on a global scale has been continuously increasing, becoming an important growth point in my country's service trade. In order to implement the national traditional Chinese medicine development str
    2025-09-19 healthy
  • Rongchang BioTatisip's first biopharmaceutical for Sjogren's syndrome market application was accepted by CDERecently, Rongchang Biopharma (Yantai) Co., Ltd. (hereinafter referred to as "Rongchang Biopharma") announced that its independently developed innovative biopharmaceutical Tatecip (RC18) for the treatment of Sjogren's syndrome (SS) application has been accepted by the Drug Review Center (CDE) of the State Drug
    2025-09-19 healthy
  • Recommended articles
  • 父亲深度育儿参与率仅 32%!明星示范引发全民反思近日,一则关于“父亲深度育儿参与率”
    2025-09-19 Mother and baby
  • 周杰伦代言防走失背包销量暴涨 180%!明星育儿带火亲子产品近日,周杰伦代言的某品牌防走
    2025-09-19 Mother and baby
  • 椎管内麻醉实现九成减痛分娩!10 分钟起效剂量仅剖宫产 1/10近日,一项关于椎管内麻醉在分
    2025-09-19 Mother and baby
  • Friendly links
    Dividing line